Members of the glutathione and ABC-transporter families are associated with clinical outcome in patients with diffuse large B-cell lymphoma.
about
Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive reviewIdentification of predictive pathways for non-hodgkin lymphoma prognosisComparative analysis of putative pathogenesis-related gene expression in two Rhizoctonia solani pathosystems.Inhibition of glutathione peroxidase mediates the collateral sensitivity of multidrug-resistant cells to tioproninABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma.Lipid peroxidation and glutathione peroxidase activity relationship in breast cancer depends on functional polymorphism of GPX1.Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets.Utility of subsequent conventional dose chemotherapy in relapsed/refractory transplant-eligible patients with diffuse large B-cell lymphoma failing platinum-based salvage chemotherapy.Drug transporter pharmacogenetics in nucleoside-based therapies.Multidrug resistance in the chronic lymphoproliferative disorders.Manipulation of cellular redox parameters for improving therapeutic responses in B-cell lymphoma and multiple myeloma.Mitochondria and redox homoeostasis as chemotherapeutic targets.Expression of multidrug resistance 1 gene in B-cell lymphomas: association with follicular dendritic cells.Two different docetaxel resistant MCF-7 sublines exhibited different gene expression pattern.Pathway activation in large B-cell non-Hodgkin lymphoma cell lines by doxorubicin reveals prognostic markers of in vivo response.Oxidative stress and redox state-regulating enzymes have prognostic relevance in diffuse large B-cell lymphoma.Y-box binding protein-1 expression in diffuse large B-cell lymphoma: an impact on prognosis in the rituximab era.An analysis of the role of follicular lymphoma-associated fibroblasts to promote tumor cell viability following drug-induced apoptosis.
P2860
Q27304386-9EA51032-9643-49A9-BB91-AD571171C58DQ30497902-B82F3229-C082-471A-B8A1-F5D3CD8FB50AQ31030811-492D8202-B7C4-46C4-8BB0-5783C0DD5FABQ33985320-3C6A7A2A-123D-4EF3-B929-0BCB2C9140BFQ35190691-83067890-C19A-43C4-9D1D-C49BB9B42B31Q35800890-DA5940BB-DF19-4CC7-8C14-148BB760EFD4Q37187642-8B3F77AB-3584-4331-A68A-D6F06117CDA6Q37293519-423937A6-CE7E-4530-B712-DFF552CC0400Q37760954-C6E4430F-C13F-4AF9-9C75-CD701D990E79Q37771031-21BD6F29-0EC9-401E-8B00-4E85FC74A03AQ37940343-43A8A94B-39E1-4AC3-8029-73A03BA53ACCQ38238632-3A6DF8B2-19E1-422E-AFE7-CF11970949C5Q39206827-2C9BF301-D2F8-4B76-A998-4B5C8B98E82EQ39514723-2B90E3DA-8F0C-4CEF-8839-0D29042FF914Q39914215-D8143272-12A9-41F1-A9F6-2BDB3D835410Q42355782-F0D22B42-6F9C-4517-AC5B-2BADD516D825Q42867439-D97D1B04-90F3-4311-BA54-48303CC1FBD7Q52949164-EA57FC90-8E3E-418D-A2B9-B07DF70EC205
P2860
Members of the glutathione and ABC-transporter families are associated with clinical outcome in patients with diffuse large B-cell lymphoma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Members of the glutathione and ...... diffuse large B-cell lymphoma.
@ast
Members of the glutathione and ...... diffuse large B-cell lymphoma.
@en
type
label
Members of the glutathione and ...... diffuse large B-cell lymphoma.
@ast
Members of the glutathione and ...... diffuse large B-cell lymphoma.
@en
prefLabel
Members of the glutathione and ...... diffuse large B-cell lymphoma.
@ast
Members of the glutathione and ...... diffuse large B-cell lymphoma.
@en
P2093
P2860
P1433
P1476
Members of the glutathione and ...... diffuse large B-cell lymphoma.
@en
P2093
Charalambos Andreadis
Jane Houldsworth
Peter Wahl
Phyllis A Gimotty
Rachel Hammond
Stephen J Schuster
Timothy R Rebbeck
P2860
P304
P356
10.1182/BLOOD-2006-09-047621
P407
P577
2006-12-19T00:00:00Z